Cart
sales@molnova.com
Minodronic acid
CAS No. 180064-38-4
Minodronic acid( —— )
Catalog No. M37531 CAS No. 180064-38-4
Minodronic acid(YM-529) is a P2X2/3 receptor antagonist with anticancer activity, directly or indirectly inhibiting the proliferation of cancer cells and inducing apoptosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 38 | In Stock |
|
| 25MG | 61 | In Stock |
|
| 50MG | 86 | In Stock |
|
| 100MG | 120 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 303 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMinodronic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionMinodronic acid(YM-529) is a P2X2/3 receptor antagonist with anticancer activity, directly or indirectly inhibiting the proliferation of cancer cells and inducing apoptosis.
-
DescriptionMinodronic acid (YM-529) is a third-generation bisphosphonate that directly and indirectly prevents proliferation, induces apoptosis, and inhibits metastasis of various types of cancer cells. Minodronic acid (YM-529) is an antagonist of purinergic P2X2/3 receptors involved in pain.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetP2X Receptor
-
RecptorP2X Receptor | Apoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number180064-38-4
-
Formula Weight322.15
-
Molecular FormulaC9H12N2O7P2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 5 mg/mL (15.52 mM) DMSO : < 1 mg/mL (insoluble or slightly soluble)
-
SMILESOC(Cc1cnc2ccccn12)(P(O)(O)=O)P(O)(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sato K, et al. A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo. Br J Cancer. 2006 Nov 20;95(10):1354-61.?
molnova catalog
related products
-
AZ10606120 dihydroch...
AZ10606120 dihydrochloride has anti-depressant effects and reduces tumour growth.
-
PPADS tetrasodium
PPADS tetrasodiuma is a potent P2X receptor antagonist and inhibitor of the inverse mode of Na/Ca2? exchange in guinea pig airway smooth muscle and is neuroprotective against glutamate/NMDA toxicity.PPADS tetrasodiuma inhibits P2X1, P2X-2, P2X-3, and P2X- 5. 5.
-
AZD-9056
A potent, selective, orally bioavailable P2X7 receptor antagonist; inhibits release of pro-inflammatory mediators from isolated human peripheral monocytes (IL-1β and IL-18) and human alveolar macrophages (IL-1β) with IC50 values of 10-13 nM.
